Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tuberculosis, Multidrug-Resistant

"Tuberculosis, Multidrug-Resistant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information
Definition  |  Details  |  More General Concepts  |  Related Concepts  |  More Specific Concepts
Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.


publications
Timeline   |   Most Recent
This graph shows the total number of publications written about "Tuberculosis, Multidrug-Resistant" by people in Harvard Catalyst Profiles by year, and whether "Tuberculosis, Multidrug-Resistant" was a major or minor topic of these publication.
Bar chart showing 493 publications over 31 distinct years, with a maximum of 39 publications in 2016
To see the data from this visualization as text, click here.
Related Networks
People
Explore
_
Similar Concepts
_
Top Journals 
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.